Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): A new drug of abuse

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 1043-1052

  Sparago, Merrill ^a   Wlos, Jennifer ^a   Yuan, Jie ^a   Hatzidimitriou, George ^a   Tolliver, James ^c   Dal Cason, Terry A ^d   Katz, Jonathan ^b   Ricaurte, George ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NIDA Addiction Research Center   (United States)

^c Drug Enforcement Administration   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLAMINO 1 PHENYLPROPANONE; AMPHETAMINE DERIVATIVE; DOPAMINE; METHCATHINONE; PAROXETINE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG STRUCTURE; ENANTIOMER; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; LONG TERM EXPOSURE; MALE; METHYLATION; MOUSE; NERVE CELL LESION; NEUROTOXICITY; PRIORITY JOURNAL; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MOTOR ACTIVITY; PAROXETINE; PROPIOPHENONES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STEREOISOMERISM; STREET DRUGS;

EID: 0030440957     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. BAUMGARTEN, R. L.: Organic Chemistry: A Brief Survey, John Wiley and Sons, New York, 1978.
2. BUNNEY, B., WALTERS, J., KUHAR, M., ROTH, R. AND AGHAJANIAN, G.: D- and L-amphetamine enantiomers: Comparative potencies in affecting firing of central dopaminergic and noradrenergic neurons. Psychopharmacol. Commun. 1: 177-182, 1975.
3. CALDWELL, J.: Pharmacology of the amphetamines and related stimulants. In Amphetamine And Related Stimulants: Chemical, Biological, Clinical abd Sociological Aspects, ed. by J. Caldwell, pp. 1-11, CRC Press, Boca Raton, FL, 1980.
4. DAL CASON, T. A.: The identification of cathinone and methcathinone. Microgram 26: 313-328, 1992.
5. ELIEL, E., WILEN, S. H.: Stereochemistry of Organic Compounds, John Wiley and Sons, New York, 1994.
6. ELLISON, G., EISON, M. S., HUBERMAN, H. S. AND DANIEL, F.: Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201: 276-278, 1978.
7. EMERSON, T. S. AND CISEK, J. E.: Methcathinone: A Russian designer amphetamine infiltrates the rural midwest. Ann. Emerg. Med. 22: 129-135, 1993.
8. FAIRCHILD, M. AND ALLES, G.: The central locomotor stimulatory activity and acute toxicity of the ephedrine and norephedrine enantiomers in mice. J. Pharmacol. Exp. Ther. 158: 135-139, 1967.
9. FERRIS, R. M., BURSCU, J. E. AND MAXWELL, R. A.: Steroeisomeric aspects of psychotherapeutic drugs. In Psychotherapeutic Drugs Part I: Principles, ed. by. E. Usdin and I. S. Forrest, pp. 83-137, Marcel Dekker, New York, 1976.
10. FINK, R. P. AND HEIMER, L.: Two methods for the selective silver-impregnation of degenerating axons and their synptic endings in the central nervous system. Brain Res. 4: 369-374, 1967.
11. FINNEY, D. J.: Statistical Methods in Biological Assay, 2nd ed., Hafner, New York, 1964.
12. FULLER, R. W. AND HEMRICK-LUECKE, S. K.: Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine. Neuropharmacology 21: 433-438, 1982.
13. GARATTINI, S., CACCIA, S., MENNINI, T., SAMANIN, R., CONSOLO, S. AND LADINSKI, H.: Biochemical pharmacology of the anorectic drug fenfluramine: A review. Curr. Med. Res. Opin. 6: suppl. 1, 15-27, 1979.
14. GLENNON, R., YOUNG, R., MARTIN, B. AND DAL CASON, T.: Methcathinone ("Cat"): Enantiomeric potency comparison. Pharmacol. Biochem. Behav. 50: 601-606, 1995.
15. GLENNON, R. A., YOUSIF, M., NAIMAN, N. AND KALIX, P.: Methcathinone: A new and potent amphetamine-like agent. Pharmacol. Biochem. Behav. 26: 547-551, 1987.
16. GOLDSTONE, M. S.: "Cat": Methcathinone - A new drug of abuse. J. Am. Med. Assoc. 269: 19, 1993.
17. GYGI, M. P., GIBB, J. W. AND HANSON, G. R.: Methcathinone: An initial study of its effects on monoaminergic systems. J. Pharmacol. Exp. Ther. 276: 1066-1072, 1996.
18. HOTCHKISS, A. AND GIBB, J.: Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214: 257-263, 1980.
19. HUTCHALEELAHA A., SUKBUNTHERNG, J., CHOW, H. AND MAYERSOHN, M.: Disposition kinetics of d- and 1-amphetamine following intravenous administration of racemic amphetamine to rats. Drug Metab. Dispos. 22: 406-411, 1994.
20. 3H]dopamine release from superfused rat brain. Eur. J. Pharmacol. 132: 269-276, 1986.
21. JOHNSON, M. AND NICHOLS, D.: Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine. Pharmacol. Biochem. Behav. 36: 105-109, 1990.
22. KALIX, P. AND BRAENDEN, O.: Pharmacological aspects of the chewing of Khat leaves. Pharmacol. Rev. 37: 149-164, 1985.
23. KAMINSKI, B. J. AND GRIFFITHS, R. R.: Intravenous self-administration of methcathinone in the baboon. Pharmacol. Biochem. Behav. 47: 981-983, 1994.
24. 1N-dimethylamphetamine in squirrel monkeys. Psychopharmacology 107: 315-318, 1992.
25. KLEVEN, M., WOOLVERTON, W. AND SEIDEN, L.; Evidence that both intragastric and subcutaneous administration of methylenedioxymethamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Res. 488: 121-122, 1989.
26. KUCZENSKI, R.: Biochemical actions of amphetamine and other stimulants. In Stimulants: Neurochemical, Behavioral and Clinical Perspectives, ed. by I. Creese, pp. 31-61, Raven Press, New York, 1983.
27. KUCZENSKI, R. AND SEGAL, D.: Differential effects of D- and L-amphetamine and methylphenidate on rat striatal biosynthesis. Eur. J. Pharmacol. 30: 244-249, 1975.
28. LEBELLE, M. J., SAVARD, C., DAWSON, B. A., BLACK, D. B., KATYAL, L. K., ZHCEK, F. AND BY, A. W.: Chiral indentification and determination of ephedrine, pseudoephedrine, methamphetamine and methcathinone by gas chromatography and nuclear magnetic resonance. Forensic Sci. Int. 71: 215-223, 1995.
29. MARCH, J.: Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, McGraw-Hill Book Company, New York, 1968.
30. MARKANTONIS, S. L., KYROUDIS, A. AND BECKETT, A. H.: The stereoselective metabolism of dimethylpropion and monomethylpropion. Biochem. Pharmacol. 35: 529-532, 1986.
31. MARTELLO, A., SPARAGO, M., YUAN, J., HATZIBIMITRIOU, G. AND RICAURTE, G. A.: Behavioral and neurotoxic effects of methcathinone. Soc. Neurosci. Abstr. 20: 1028, 1994.
32. MARQUARDT, G., DISTEFANO, V. AND LING, L.: Pharmacological and toxicological effects of beta-3,4-methylenedioxyamphetamine isomere. Biol. Appl. Pharmacol. 45: 675-683, 1978.
33. MCCANN, U. D., HATZIDIMITRIOU, G., RIDENOUR, A., FISHER, C., KATZ, J. AND RICAURTE, G. A.: Dexfenfluramine neurotoxicity in humans: Further preclinical evidence that concern is warranted. J. Pharmacol. Exp. Ther. 269: 792-798, 1994.
34. MOORE, K. E.: Amphetamines: Biochemical and behavioral actions in animals. In Handbook of Psychopharmacology, ed. by L. L. Iverson, S. D. Iversen and S. H. Snyderds, vol. II, pp. 41-98, Plenum Press, New York, 1978.
35. NENCINI, P. AND AHMED, A.: Khat consumption: A pharmacological review. Drug Alcohol Depend. 23: 19-29, 1989.
36. NWANZE, G. AND JONSSON, G.: Amphetamine neurotoxicity on dopamine nerve terminals in the caudate nucleus of mice. Neurosci. Lett. 26: 163-198, 1981.
37. O'CALLAGHAN, J. AND MILLER, D.: Neurotoxicity profiles of substituted amphetamines in the C57B1/6J mouse. J. Pharmacol. Exp. Ther. 20: 1-11, 1994.
38. RICAURTE, G. A.: Studies of MDMA-induced neurotoxicity in nonhuman primates: A basis for evaluating long-term effects in humans. In Pharmacology and Toxicology of Amphetamines and Related Designer Drugs, ed. by K. Asghar and E. DeSouza, pp. 306-322, NIDA Research Monograph 94, 1989.
39. RICAURTE, G. A., SCHUSTER, C. R. AND SEIDEN, L. S.: Long-term effects of repeated d-methylamphetamine administration on dopaminergic and serotonergic neurons in the rat brain: A regional study. Brain Res. 193: 153-160, 1980.
40. RICAURTE, G. A., FULLER, R. W., PERRY, K. W., SEIDEN, L. S. AND SCHUSTER, C. R.: Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacology 22: 1165-1169, 1983.
41. RICAURTE, G. A., GUILLERY, R. W., SEIDEN, L. S. AND SCHUSTER, C. R.: Nerve terminal degeneration after a single injection of d-amphetamine in iprindole-treated rats: Relation to selective long-lasting dopamine depletion. Brain Res. 281: 378-382, 1984.
42. RICAURTE, G. A., DELANNEY, L. E., IRWIN, I. AND LANGSTON, J. W.: Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: An illicit analog of methamphetamine. Brain Res. 490: 301-306, 1989.
43. RICAURTE, G. A., IRWIN, I., FORNO, L. S., DELANNEY, L. E., LANGSTON, E. AND LANGSTON, J. W.: Aging and MPTP-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res. 403: 43, 1987.
44. RICAURTE, G. A. AND MCCANN, U. D.: Neurotoxic amphetamine analogues: Effects in monkeys and implications for humans. Ann. N.Y. Acad. Sci. 648: 371-382, 1992.
45. RICAURTE, G. A., MARTELLO, A. L., KATZ, J. L. AND MARTELLO, M. B.: Lasting effects of 3,4-methylenedioxymethamphetamine on central serotonergic neurons in non-human primates: Neurochemical observations. J. Pharmacol. Exp. Ther. 261: 616-622, 1992.
46. RICAURTE, G., WONG, D., SZABO, Z, YOKOI, F., SCHEFFEL, U., MATHEWS, W., RAVERT, H. AND DANNALS, R.: Reductions in brain dopamine and serotonin transporters detected in humans previously exposed to repeated high doses of methcathinone using PET. Soc. Neurosci. Abstr. 22: 1915, 1996.
47. SANCHEZ, M. E., MARIN, A. AND FORN, J.: Actividad anorexigena de algunos derivados de la alpha-aminoacetofenona. Arch. Farmacol. Toxicol. 5: 165-168, 1979.
48. SCHMIDT, C., LEVIN, J. AND LOVENBERG, W.: In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36: 747-755, 1987.
49. SCHMIDT, C., RITTER, J., SONSALLA, P., HANSON, G. AND GIBB, J.: Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233: 539-544, 1985.
50. SCHMIDT, C. J.: Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240: 1-7, 1987.
51. SCHORNO, X. AND STEINEGGER, E.: Studies on the chemical composition of Khat: The phenylalkylamines of Catha edulis Forsk. The absolute configuration of cathinone. United Nations Narcotics Library, 1978.
52. SEIDEN, L. S., SABOL, K. E. AND RICAURTE, G. A.: Amphetamine: Effects on cathecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33: 639-677, 1993.
53. SEIDEN, L. S. AND RICAURTE, G. A.: Neurotoxicity of methamphetamine and related drugs. In Psychopharmacology: A Generation of Progress, ed. by H. Y. Meltzer, pp. 359-366, Raven Press, NY, 1987.
54. SEMKIN E. P., SOROKIN V. I. AND SAVENKO V. G.: Examination of Ephedrone. Microgram 26: 11-15, 1993.
55. SNEDECOR, G. W. AND COCHRAN, W. G.: Statistical Methods, 6th ed., pp. 135-171, Iowa State University Press, Ames, IA, 1967.
56. STEELE, T., MCCANN, U. AND RICAURTE, G. A.: 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Pharmacology and toxicology in animals and humans. Addiction 89: 539-551, 1994.
57. 3H]monoamines into synaptosomes from different regions of the rat brain. Biochem. Pharmacol. 36: 2297-2303, 1987.
58. STERANKA, L. R.: Stereospecific long-term effects of amphetamine on striatal dopamine neurons in rate. Eur. J. Pharmacol. 76: 443-446, 1981.
59. STONE, D., JOHNSON, M., HANSON, G. AND GIBB, J.: Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 247: 79-87, 1988.
60. STONE, D., HANSON, G. AND GIBB, J.: Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats. Neuropharmacology 26; 1657-1661, 1987.
61. TANAKA, D.: Thalamic projections of the dorsomedial prefrontal cortex in the rhesus monkey (Macaca Mulata). Brain Res. 110: 21-38, 1976.
62. TOLLIVER, J. M.: Methcathinone: A new amphetamine-like drug of abuse. In National Institute on Drug Abuse Research Monograph Series 153, p. 406, 1995.
63. VAN DER SCHOOT, J. B., ARIENS, E. J., ROSSUM, J. M. AND HURKMANS, J. A.: Phenylisopropylamines Derivatives, Structure and Action, 9, pp. 902-907, Arzneim-Forachung, 1962.
64. WAGNER, G. C., PRESTON, K. L., RICAURTE, G. A., SCHUSTER, C. R. AND SEIDEN, L. S.: Neurochemical similarities between d,l-cathinone and d-amphetamine. Drug Alcohol Depend. 8: 279-284, 1982.
65. YOUNG, R. AND GLENNON, R.: Discriminative stimulus properties of amphetamine and structurally related phenalkylamines. Med. Res. Rev. 6: 99-130, 1986.
66. YOUNG, R. AND GLENNON, R. A.: Cocaine-Stimulus Generalization to Two New Designer Drugs: methcathinone and 4-Methylminorex. Pharmacol Biochem. Behav. 46: 229-231, 1993.
67. ZHINGEL, K. Y., DOVENSKY, W., CROSSMAN, A. AND ALLEN, A.: Ephedrone: 2-Methylamino-1-phenylpropan-1-one. J. Forensic Sci. 36: 915-920, 1991.